The $360 Billion Market that Medicine Got Wrong for 20 Years
The News
The article discusses the underappreciated market for menopause within the women's health sector, which is valued at $360 billion. It notes that menopause has been overlooked by pharmaceutical companies, employers, and investors despite affecting half the population and causing productivity losses. The article implies that this neglect represents a missed opportunity in the women's health market.
Infographic
No infographic was generated for this story. GreyNews is not leaving this spinning indefinitely.
The Analysis
Intelligence Brief
Analyzed · High confidence (78%)
Same as the summary above — this brief adds the distinct fields below.
Market valued at $360 billion
Menopause affects half the world's population.
3 claims still need verification.
No forecast extracted yet.
Key findings
Menopause has gone largely unnoticed by pharma and biotech firms, employers, and investors.
Bloomberg- Market valued at $360 billion
- Major productivity losses
Trust Breakdown
Plain English
Loaded language removedThe $360 billion dollar women’s health market is made of several categories that are often overlooked – one of which is menopause. The condition has gone largely unnoticed by pharma and biotech firms, employers, and investors, despite affecting half the world’s population and contributing to major losses in productivity.
Emotionally neutral rewrite. Same facts, calmer framing.
What's next
This angle has contested claims
Claims
Menopause has gone largely unnoticed by pharma and biotech firms, employers, and investors.
BloombergMenopause affects half the world's population.
BloombergMenopause contributes to major losses in productivity.
BloombergBias & Framing
- anchoring: The $360 billion dollar women’s health market